The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease

Cites (286)

Items 201–281 of 281

1. Chapter 20 Neuropathological hallmarks of Alzheimer's and Parkinson's diseases
   Heiko Braak, Rob A. I. de Vos, Ernst N. H. Jansen, H. Bratzke, Eva Braak · 1998 · Progress in brain research
2. THE GENETICS AND MOLECULAR PATHOLOGY OF ALZHEIMER'S DISEASE
   Dennis J. Selkoe · 2000 · Neurologic Clinics
3. IL-4-Induced Selective Clearance of Oligomeric β-Amyloid Peptide1–42 by Rat Primary Type 2 Microglia
   Shimizu, Eisuke, Kawahara, Kohichi, Kajizono, Makoto, Sawada, Makoto, Nakayama, Hitoshi · 2008 · The Journal of Immunology
4. Aβ Oligomers Induce Neuronal Cell Cycle Events in Alzheimer's Disease
   Nicholas H. Varvel, Kiran Bhaskar, Anita R. Patil, Sanjay W. Pimplikar, Karl Herrup, Bruce T. Lamb · 2008 · Journal of Neuroscience
5. Amyloid β-Peptide Oligomers Stimulate RyR-Mediated Ca 2+ Release Inducing Mitochondrial Fragmentation in Hippocampal Neurons and Prevent RyR-Mediated Dendritic Spine Remodeling Produced by BDNF
   Andrea Cristina Paula-Lima, Tatiana Adasme, Carol D. SanMartín, Adriano Silva Sebollela, Claudio A. Hetz, M. Angélica Carrasco, Sergio Teixeira Ferreira, Cecilia Hidalgo · 2010 · Antioxidants and Redox Signaling
6. Site-Specific Blockade of RAGE-V_dPrevents Amyloid-β Oligomer Neurotoxicity
   Sturchler, Emmanuel, Galichet, Arnaud, Weibel, Mirjam, Leclerc, Estelle, Heizmann, Claus W. · 2008 · The Journal of Neuroscience
7. Microglia Activated with the Toll-Like Receptor 9 Ligand CpG Attenuate Oligomeric Amyloid β Neurotoxicity in in Vitro and in Vivo Models of Alzheimer’s Disease
   Doi, Yukiko, Mizuno, Tetsuya, Maki, Yuki, Jin, Shijie, Mizoguchi, Hiroyuki, Ikeyama, Masayoshi, Doi, Minoru, Michikawa, Makoto, Takeuchi, Hideyuki, Suzumura, Akio · 2009 · The American Journal of Pathology
8. Alzheimer's-associated Aβ oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal
   Pitt, Jason, Roth, William, Lacor, Pascale, Smith, Amos B., Blankenship, Matthew, Velasco, Pauline, De Felice, Fernanda, Breslin, Paul, Klein, William L. · 2009 · Toxicology and Applied Pharmacology
9. Brain Oxidative Stress in Animal Models of Accelerated Aging and the Age-related Neurodegenerative Disorders, Alzheimers Disease and Huntingtons Disease
   David Allan Butterfield, Beverly J. Howard, Michael LaFontaine · 2001 · Current Medicinal Chemistry
10. Non-Fibrillar β-Amyloid Protein is Associated with Smooth Muscle Cells of Vessel Walls in Alzheimer Disease
    Janusz Frackowiak, Albina Żółtowska, Henryk M. Wı́sniewski · 1994 · Journal of Neuropathology & Experimental Neurology
11. Experience-Dependent Regulation of the Immediate-Early Gene Arc Differs across Brain Regions
    Michy P. Kelly, Sam A. Deadwyler · 2003 · Journal of Neuroscience
12. PI3 kinase signaling is involved in Aβ-induced memory loss in Drosophila
    Hsueh‐Cheng Chiang, Lei Wang, Zuolei Xie, Alice Yau, Yi Zhong · 2010 · Proceedings of the National Academy of Sciences
13. The E693Δ Mutation in Amyloid Precursor Protein Increases Intracellular Accumulation of Amyloid β Oligomers and Causes Endoplasmic Reticulum Stress-Induced Apoptosis in Cultured Cells
    Nishitsuji, Kazuchika, Tomiyama, Takami, Ishibashi, Kenichi, Ito, Kazuhiro, Teraoka, Rie, Lambert, Mary P., Klein, William L., Mori, Hiroshi · 2009 · The American Journal of Pathology
14. Genetic linkage map of human chromosome 21
    Rudolph E. Tanzi · 1988 · Genomics
15. Hyperinsulinaemia and Alzheimer's Disease
    George Razay, Gordon Keith Wilcock · 1994 · Age and Ageing
16. Insulin-Resistant Brain State after Intracerebroventricular Streptozotocin Injection Exacerbates Alzheimer-like Changes in Tg2576 AβPP-Overexpressing Mice
    Plaschke, Konstanze, Kopitz, Juergen, Siegelin, Markus, Schliebs, Reinhard, Salkovic-Petrisic, Melita, Riederer, Peter, Hoyer, Siegfried · 2010 · Journal of Alzheimer s Disease
17. Purification and Characterization of Brain Clusterin
    Oda T, Giulio Maria Pasinetti, Heinz H. Osterburg, C. Anderson, S.A. Johnson, Caleb E. Finch · 1994 · Biochemical and Biophysical Research Communications
18. Insulin signaling effects on memory and mood
    Reagan, Lawrence P · 2007 · Current Opinion in Pharmacology
19. Wnt-5aoccludes Aβ oligomer-induced depression of glutamatergic transmission in hippocampal neurons
    Waldo F. Cerpa, Ginny G. Farı́as, Juan Alejandro Godoy, Marco Fuenzalida, Christian Bonansco, Nibaldo C. Inestrosa · 2010 · Molecular Neurodegeneration
20. Insulin binding to brain capillaries is reduced in genetically obese, hyperinsulinemic Zucker rats
    Michael W. Schwartz, Dianne Figlewicz Lattemann, Steven E. Kahn, Denis G. Baskin, M. R. C. Greenwood, Daniel Porte · 1990 · Peptides
21. Microtubule-associated Protein MAP1A, MAP1B, and MAP2 Proteolysis during Soluble Amyloid β-Peptide-induced Neuronal Apoptosis
    Alexandre Fifre, Isabelle Sponne, Violette Koziel, Badreddine Kriem, Frances T. Yen, Bernard E. Bihain, J L Olivier, Thierry Oster, Thierry Pillot · 2005 · Journal of Biological Chemistry
22. Generation and Therapeutic Efficacy of Highly Oligomer-Specific β-Amyloid Antibodies
    Hillen, Heinz, Barghorn, Stefan, Striebinger, Andreas, Labkovsky, Boris, Müller, Reinhold, Nimmrich, Volker, Nolte, Marc W., Perez-Cruz, Claudia, van der Auwera, Ingrid, van Leuven, Fred et al. · 2010 · The Journal of Neuroscience
23. Microglial Receptor for Advanced Glycation End Product-Dependent Signal Pathway Drives β-Amyloid-Induced Synaptic Depression and Long-Term Depression Impairment in Entorhinal Cortex
    Origlia, Nicola, Bonadonna, Camilla, Rosellini, Alfredo, Leznik, Elena, Arancio, Ottavio, Yan, Shirley ShiDu, Domenici, Luciano · 2010 · The Journal of Neuroscience
24. Architecture of the Alzheimer?s A�P Ion Channel Pore
    Nelson J. Arispe · 2004 · The Journal of Membrane Biology
25. Prion Protein: Orchestrating Neurotrophic Activities
    Vilma Regina Martins, Flávio H. Beraldo, Glaucia N. M. Hajj, Marilene Hohmuth Lopes, Kil Sun Lee, Marco A. M. Prado, Rafael Linden · 2010 · Caister Academic Press eBooks
26. Type 2 diabetes mellitus, dyslipidemia, and Alzheimer’s disease
    Carlsson, Cynthia M. · 2010 · Journal of Alzheimer s Disease
27. Apoptotic Neuronal Cell Death Induced by the Non-fibrillar Amyloid-β Peptide Proceeds through an Early Reactive Oxygen Species-dependent Cytoskeleton Perturbation
    Isabelle Sponne, Alexandre Fifre, Béatrice Drouet, Christophe Klein, Violette Koziel, Martine Pinçon‐Raymond, J L Olivier, Jean Chambaz, Thierry Pillot · 2003 · Journal of Biological Chemistry
28. Apolipoprotein E promotes the binding and uptake of β-amyloid into Chinese hamster ovary cells in an isoform-specific manner
    D.-S. Yang, David Henry Small, U. Seydel, Jonathan D. Smith, Joachim Franz Hallmayer, Sam Gandy, Ralph Nigel Martins · 1999 · Neuroscience
29. Insulin resistance contributes to aberrant stress responses in the Tg2576 mouse model of Alzheimer's disease
    PEDERSEN, W, FLYNN, E · 2004 · Neurobiology of Disease
30. Amyloid‐β oligomers impair fear conditioned memory in a calcineurin‐dependent fashion in mice
    Kelly T. Dineley, Rakez Kayed, Volker Neugebauer, Yu Fu, Wenru Zhang, Lindsay C. Reese, Giulio Taglialatela · 2010 · Journal of Neuroscience Research
31. Aβ40 Oligomers Identified as a Potential Biomarker for the Diagnosis of Alzheimer's Disease
    Gao, Carol Man, Yam, Alice Y., Wang, Xuemei, Magdangal, Erika, Salisbury, Cleo, Peretz, David, Zuckermann, Ronald N., Connolly, Michael D., Hansson, Oskar, Minthon, Lennart et al. · 2010 · PLoS ONE
32. A β 1-42 Induces Mild Endoplasmic Reticulum Stress in an Aggregation State–Dependent Manner
    Sidhartha M. Chafekar, Jeroen J.M. Hoozemans, Rob Zwart, Frank Baas, Wiep Scheper · 2007 · Antioxidants and Redox Signaling
33. Role of the Wnt receptor Frizzled-1 in presynaptic differentiation and function
    Varela-Nallar, Lorena, Grabowski, Catalina P, Alfaro, Iván E, Alvarez, Alejandra R, Inestrosa, Nibaldo C · 2009 · Neural Development
34. Aberrant early-phase ERK inactivation impedes neuronal function in fragile X syndrome
    Kim, Soong Ho, Markham, Julie A., Weiler, Ivan Jeanne, Greenough, William T. · 2008 · Proceedings of the National Academy of Sciences
35. Aβ Oligomers Induce Glutamate Release from Hippocampal Neurons
    Jordano Brito‐Moreira, Andrea Cristina Paula-Lima, Theresa R. Bomfim, Fabio Ferreira de Oliveira, Fernando J. Sepúlveda, Fernando Garcia De Mello, Luis Gerardo Aguayo, Rogério Panizzutti, Sergio Teixeira Ferreira · 2011 · Current Alzheimer Research
36. Amyloid-β Triggers the Release of Neuronal Hexokinase 1 from Mitochondria
    Saraiva, Leonardo M., Seixas da Silva, Gisele S., Galina, Antonio, da-Silva, Wagner S., Klein, William L., Ferreira, Sérgio T., De Felice, Fernanda G. · 2010 · PLoS ONE
37. Activation of D1/D5 Dopamine Receptors Protects Neurons from Synapse Dysfunction Induced by Amyloid-β Oligomers
    Jürgensen, Sofia, Antonio, Leandro L., Mussi, Gabriela E.A., Brito-Moreira, Jordano, Bomfim, Theresa R., De Felice, Fernanda G., Garrido-Sanabria, Emilio R., Cavalheiro, Ésper A., Ferreira, Sergio T. · 2011 · Journal of Biological Chemistry
38. Membrane cholesterol interferes with neuronal apoptosis induced by soluble oligomers but not fibrils of the amyloid‐β peptide
    Isabelle Sponne, Alexandre Fifre, Badreddine Kriem, Violette Koziel, Bernard E. Bihain, Thierry Oster, J L Olivier, Thierry Pillot · 2004 · The FASEB Journal
39. Murine models of Alzheimer's disease and their use in developing immunotherapies
    Thomas Wısnıewskı, Einar M. Sigurdsson · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
40. On BC1 RNA and the fragile X mental retardation protein
    Iacoangeli, Anna, Rozhdestvensky, Timofey S., Dolzhanskaya, Natalia, Tournier, Barthélémy, Schütt, Janin, Brosius, Jürgen, Denman, Robert B., Khandjian, Edouard W., Kindler, Stefan, Tiedge, Henri · 2008 · Proceedings of the National Academy of Sciences
41. Insulin rescues amyloid β-induced impairment of hippocampal long-term potentiation
    Lee, Cheng-Che, Kuo, Yu-Min, Huang, Chiung-Chun, Hsu, Kuei-Sen · 2009 · Neurobiology of Aging
42. Metabolic changes in rat brain following intracerebroventricular injections of streptozotocin: A model of sporadic Alzheimer’s disease
    Labak, M., Foniok, T., Kirk, D., Rushforth, D., Tomanek, B., Jasiński, A., Grieb, P. · 2010 · Acta neurochirurgica. Supplementum
43. Femtomole Immunodetection of Synthetic and Endogenous Amyloid-β Oligomers and Its Application to Alzheimer's Disease Drug Candidate Screening
    Lei Chang, Lara Bakhos, Zhiqiang Wang, Duane L. Venton, William L. Klein · 2003 · Journal of Molecular Neuroscience
44. Small non-fibrillar assemblies of amyloid β-protein bearing the Arctic mutation induce rapid neuritic degeneration
    Brian M. Whalen, Dennis J. Selkoe, Dean M. Hartley · 2005 · Neurobiology of Disease
45. Amyloid-beta oligomers increase the localization of prion protein at the cell surface: PrPC trafficking and Alzheimer’s disease
    Caetano, Fabiana A., Beraldo, Flavio H., Hajj, Glaucia N. M., Guimaraes, Andre L., Jürgensen, Sofia, Wasilewska-Sampaio, Ana Paula, Hirata, Pedro H. F., Souza, Ivana, Machado, Cleiton F., Wong, Daisy Y.-L. et al. · 2011 · Journal of Neurochemistry
46. Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
    Mauro Fà, Ian J. Orozco, Yitshak I. Francis, Faisal Saeed, Yimin Gong, Ottavio Arancio · 2010 · Journal of Visualized Experiments
47. Fresh Evidence Points to an Old Suspect: Calcium
    Marx, Jean · 2007 · Science
48. Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease
    Schaeffer, Evelin L., Forlenza, Orestes V., Gattaz, Wagner F. · 2009 · Psychopharmacology
49. Type II diabetes in mild cognitive impairment and Alzheimer’s disease: Results from a prospective population-based study in Germany
    Toro, Pablo, Schönknecht, Peter, Schröder, Johannes · 2009 · Journal of Alzheimer s Disease
50. Exacerbation of poststroke dementia by type 2 diabetes is associated with synergistic increases of β-secretase activation and β-amyloid generation in rat brains
    T. Zhang, Bai-Shen Pan, Baosheng Zhao, L.-M. Zhang, Ya-Lin Huang, Feng Sun · 2009 · Neuroscience
51. Neuropathology and the Neuroinflammation Idea
    Robert Emil Mrak · 2009 · Journal of Alzheimer s Disease
52. A Neprilysin Polymorphism and Amyloid-β Plaques after Traumatic Brain Injury
    Victoria E. Johnson, William B. Stewart Jr., David Ian Graham, Janice E. Stewart, Amy H. Praestgaard, Douglas H. Smith · 2009 · Journal of Neurotrauma
53. A New Target for Amyloid Beta Toxicity Validated by Standard and High-Throughput Electrophysiology
    Kucku Varghese, Péter Molnár, Mainak Das, Neelima Bhargava, Stephen Lambert, Mark S. Kindy, James J. Hickman · 2010 · PLoS ONE
54. Insulin receptors and signal transduction proteins in the hypothalamo-hypophyseal system: a review on morphological findings and functional implications.
    Jürgen W. Unger, Matthias Johannes Betz · 1998 · PubMed
55. Immunohistochemical evidence for the derivation of a peptide ligand from the amyloid beta-protein precursor of Alzheimer disease.
    David Allsop, C W Wong, Shu‐ichi Ikeda · 1988 · Proceedings of the National Academy of Sciences
56. Risk factors for Azheimer’s disease during aging. Impacts of glucose/energy metabolism
    Hoyer, S. · 1998 · Journal of Neural Transmission. Supplementa
57. Early Detection of Alzheimer’s Disease with PET Imaging
    Valentina Berti, Ricardo S. Osorio, Lisa Mosconi, Yi Li, Susan De Santi, Mony J. de Leon · 2010 · Neurodegenerative Diseases
58. Diabetes type II: A risk factor for depression-Parkinson–Alzheimer?
    Riederer, Peter, Bartl, Jasmin, Laux, Gerd, Grünblatt, Edna · 2011 · Neurotoxicity Research
59. Inflammation in Alzheimer’s Disease
    Caleb E. Finch, Valter Daniel Longo, Aya Miyao, Todd E. Morgan, Irina Rozovsky, Yubei Soong, Min Wei, Zhong Xie, Hadi Zanjani · 2001 · Humana Press eBooks
60. Biological markers for early detection and pharmacological treatment of Alzheimer's disease
    Harald Juergen Hampel, Karl Broich, Yvonne C. Hoessler, Johannes Pantel · 2009 · Dialogues in Clinical Neuroscience
61. Amyloid β-peptide preconditioning reduces glutamate-induced neurotoxicity by promoting endocytosis of NMDA receptor
    Yasuaki Goto, Tetsuhiro Niidome, Akinori Akaike, Takeshi Kihara, Hachiro Sugimoto · 2006 · Biochemical and Biophysical Research Communications
62. D1-dopamine receptor abnormality in frontal cortex points to a functional alteration of cortical cell membranes in Alzheimer’s disease
    De Keyser, J., Ebinger, G., Vauquelin, G. · 1990 · Archives of Neurology
63. Peptide Blockers of the Inhibition of Neuronal Nicotinic Acetylcholine Receptors by Amyloid β
    Magdesian, Margaret H., Nery, Arthur A., Martins, A. Henrique B., Juliano, Maria Aparecida, Juliano, Luiz, Ulrich, Henning, Ferreira, Sérgio T. · 2005 · Journal of Biological Chemistry
64. PGH2‐derived levuglandin adducts increase the neurotoxicity of amyloid β1–42
    Olivier G. Boutaud, Thomas Jude Montine, Lei Chang, William L. Klein, John A. Oates · 2006 · Journal of Neurochemistry
65. Novel demonstration of amyloid-β oligomers in sporadic inclusion-body myositis muscle fibers
    Anna Nogalska, Carla D’Agostino, W. King Engel, William L. Klein, Valerie Askanas · 2010 · Acta Neuropathologica
66. Optic Nerve Damage in Shaken Baby Syndrome
    Aaron M. Gleckman, Richard J. Evans, Michael D. Bell, Thomas Wayne Smith · 2000 · Archives of Pathology & Laboratory Medicine
67. P3-134: Intraneuronal amyloid-beta oligomers cause cell death via endoplasmic reticulum stress, endosomal/lysosomal leakage, and mitochondrial dysfunction in vivo
    Umeda, Tomohiro, Tomiyama, Takami, Sakama, Naomi, Tanaka, Saya, Lambert, Mary, Klein, William, Mori, Hiroshi · 2011 · Alzheimer's & Dementia
68. Soluble oligomeric forms of beta-amyloid (Aβ) peptide stimulate Aβ production via astrogliosis in the rat brain
    J L Martínez Pérez, I. Carrero, P. Gonzalo, Juan Arévalo‐Serrano, José Miguel Sanz Anquela, Francisco J. Ortega, Manuel José Rodríguez, A. Gonzalo‐Ruiz · 2009 · Experimental Neurology
69. Basal and hyperinsulinemia-induced immunoreactive hypothalamic insulin changes in lean and genetically obese Zucker rats revealed by microdialysis
    Kyriaki Gerozissis, Martine Orosco, Claude Rouch, Stylianos Nicolaı̈dis · 1993 · Brain Research
70. Molecular Mechanisms of Neurodegenerative Diseases
    Marie‐Françoise Chesselet · 2000 · Humana Press eBooks
71. Advances on the Understanding of the Origins of Synaptic Pathology in AD
    Pascale N. Lacor · 2007 · Current Genomics
72. Extracellular and intraneuronal HMW-AbetaOs represent a molecular basis of memory loss in Alzheimer's disease model mouse
    Ayumi Takamura, Yasuhide Okamoto, Takeshi Kawarabayashi, Tatsuki Yokoseki, Masao Suzuki Shibata, Akihiro Mouri, Toshitaka Nabeshima, Hui Sun, Koji Abe, Tsuneo Urisu et al. · 2011 · Molecular Neurodegeneration
73. Formation of Soluble Oligomers and Amyloid Fibrils with Physical Properties of the Scrapie Isoform of the Prion Protein from the C-terminal Domain of Recombinant Murine Prion Protein mPrP-(121–231)
    Samantha M. Martins, Dóris J. Frosoni, Ana Maria Blanco de Martinez, Fernanda G. De Felice, Sergio Teixeira Ferreira · 2006 · Journal of Biological Chemistry
74. The metabotropic glutamate receptor agonist 1S,3R-ACPD stimulates and modulates NMDA receptor mediated excitotoxicity in organotypic hippocampal slice cultures
    Blaabjerg, Morten, Kristensen, Bjarne W., Bonde, Christian, Zimmer, Jens · 2001 · Brain Research
75. Targeting Generation of Antibodies Specific to Conformational Epitopes of Amyloid β-Derived Neurotoxins
    Lambert, Mary, Velasco, Pauline, Viola, Kirsten, Klein, William · 2009 · CNS & Neurological Disorders - Drug Targets
76. Intracerebroventricular passive immunization with anti‐oligoAβ antibody in TgCRND8
    Chauhan, Neelima B. · 2007 · Journal of Neuroscience Research
77. Amyloid-β(1−42) Fibrillar Precursors Are Optimal for Inducing Tumor Necrosis Factor-α Production in the THP-1 Human Monocytic Cell Line
    Deepa Ajit, Maria L. D. Udan, Geeta S. Paranjape, Michael R. Nichols · 2009 · Biochemistry
78. Treatment of the mild cognitive impairment (MCI)
    H. Allain, Danièle Bentué‐Ferrer, Yvette Akwa · 2007 · Human Psychopharmacology Clinical and Experimental
79. Cytotoxic Intermediates in the Fibrillation Pathway: Aβ Oligomers in Alzheimer’s Disease as a Case Study
    William L. Klein · 2007 · Springer eBooks
80. Overview and recent advances in neuropathology. Part 2: Neurodegeneration.
    C. Masters, J. Kril, G. Halliday, R. Pamphlett, S. Collins, A. Hill, C. Mclean · 2011 · Pathology (Sydney)
81. P2‐324: ICV anti‐ADDL antibody prevented early synaptic deficits in TgCRND8 mouse model of Alzheimer's disease
    Neelima B. Chauhan, Jimena Sandoval, Mary P. Lambert, William L. Klein · 2008 · Alzheimer s & Dementia